Long Term Sidus PMCF
Withdrawn before enrolling · Not applicable
Conditions studied: Osteoarthritis, Post-traumatic; Arthrosis
In brief
The objectives of this study are to assess the safety and performance of the Sidus Stem-Free Shoulder Arthroplasty System in unilateral primary total shoulder arthroplasty.
Key facts
- Study ID
- NCT04063943
- Run by
- Zimmer Biomet
- People needed
- 0
- Starts
- 2019-07-12
- Expected to finish
- 2020-03-31
- Last updated by the study team
- 2021-05-13
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient must have previously participated in the Sidus IDE clinical trial.
- Patient must not have undergone revision of the Sidus shoulder.
- Patient must be able and willing to complete the protocol required follow-up.
- Patient must be able and willing to sign the IRB/EC approved informed consent.
You may not qualify if…
- Patient is a prisoner.
- Patient is a current alcohol or drug abuser.
- Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions.
- Patient did not previously participate in the Sidus IDE clinical trial.
- Patient no longer has Sidus shoulder implanted.
Where it is running
- Norton Orthopaedic & Sports Medicine — Louisville, Kentucky, United States
- MedStar Health — Baltimore, Maryland, United States
- Rothman Institute — Philadelphia, Pennsylvania, United States
- The Rothman Institute — Philadelphia, Pennsylvania, United States
- University of Calgary Sports Medicine Clinic — Calgary, Alberta, Canada
- Kingston General Hospital — Kingston, Ontario, Canada
- St. Joseph's Health Care London - Hand and Upper Limb Centre — London, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.